“Using longitudinal LASI-DAD data, we found that accelerated epigenetic aging was associated with higher follow-up levels and steeper increases in GFAP and NfL, particularly for clocks capturing multisystem physiological dysregulation and mortality risk (PhenoAge, GrimAge2, SystemsAge, and PhysAge)"

Grateful to have spoken at #BTBA2025 last week!

I shared our work on SystemsAge, which utilizes epigenetic biomarkers to quantify system-specific aging.

We built SystemsAge, a tool that measures aging in 11 organ systems from a single blood draw.
It’s now in use across longevity clinics, biotech trials, and academic research.

Excited to be speaking at BTBA 2025 at Harvard, where I’ll share our recent work on SystemsAge—an AI-driven tool for measuring organ-level aging.

#BTBA2025 #SystemsAge #LongevityScience #PrecisionAging #AIinBiotech #HealthyLongevity #HarvardEvents